Loading…

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

Although anatomical barriers and soluble mediators have been implicated in immune privilege, it appears that the apoptotic cell death of Fas+ cells by tissue-associated CD95 ligand (Fas ligand, FasL) is an important component. One clinical example of the function of an immune privileged site is the...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 1997-02, Vol.99 (3), p.396-402
Main Authors: Stuart, P M, Griffith, T S, Usui, N, Pepose, J, Yu, X, Ferguson, T A
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c435t-ee581354244251c8810b53aed53c3579d5e4e869511d76ea1edc251a834a24763
cites
container_end_page 402
container_issue 3
container_start_page 396
container_title The Journal of clinical investigation
container_volume 99
creator Stuart, P M
Griffith, T S
Usui, N
Pepose, J
Yu, X
Ferguson, T A
description Although anatomical barriers and soluble mediators have been implicated in immune privilege, it appears that the apoptotic cell death of Fas+ cells by tissue-associated CD95 ligand (Fas ligand, FasL) is an important component. One clinical example of the function of an immune privileged site is the success of human corneal transplants, where a very high percentage of transplants accept without tissue matching or immunosuppressive therapy. Since the mouse cornea expresses abundant Fas ligand and immune privilege has been implicated in the success of these transplants, we examined the role of FasL in corneal transplantation. Our results show that human corneas express functional FasL capable of killing Fas+ lymphoid cells in an in vitro culture system. Using a mouse model for corneal allograft transplantation, FasL+ orthografts were accepted at a rate of 45%, whereas FasL- grafts, or normal grafts transplanted to Fas- mice, were rejected 100% of the time. Histological analysis found that FasL+ grafts contained apoptotic mononuclear cells indicating the induction of apoptosis by the graft, while rejecting FasL- corneas contained numerous inflammatory cells without associated apoptosis. Taken together our results demonstrate that FasL expression on the cornea is a major factor in corneal allograft survival and, thus, we provide an explanation for one of the most successful tissue transplants performed in humans.
doi_str_mv 10.1172/jci119173
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_507812</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78819894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-ee581354244251c8810b53aed53c3579d5e4e869511d76ea1edc251a834a24763</originalsourceid><addsrcrecordid>eNpVkE9LAzEQxXNQaq0e_ADCnsQeVvO3yR48yGq1UtCDnkOana0p6aYmuwW_vSstRWFgDu_3Zh4PoQuCbwiR9HZlHSEFkewIDTGmJC8kUyfoNKUVxoRzwQdoUGBKsaRD9FY-FCLzbmmaKruemjQf566pOgtVZjZh04bkUtZPAxZSMvE7q0PMbIgNGJ8Z78MymrrNUhe3bmv8GTqujU9wvt8j9DF9fC-f8_nr06y8n-eWM9HmAEIRJjjlnApilSJ4IZiBSjDLhCwqARzUpBCEVHIChkBle9Aoxg3lcsJG6G53d9Mt1r0ITRuN15vo1n1IHYzT_5XGfepl2GqBpSK091_t_TF8dZBavXbJgvemgdAlLftIhSp4D453oI0hpQj14QfB-rdx_VLOdo337OXfUAdyXzf7AUwbfZQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78819894</pqid></control><display><type>article</type><title>CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival</title><source>EZB Free E-Journals</source><source>PubMed Central</source><creator>Stuart, P M ; Griffith, T S ; Usui, N ; Pepose, J ; Yu, X ; Ferguson, T A</creator><creatorcontrib>Stuart, P M ; Griffith, T S ; Usui, N ; Pepose, J ; Yu, X ; Ferguson, T A</creatorcontrib><description>Although anatomical barriers and soluble mediators have been implicated in immune privilege, it appears that the apoptotic cell death of Fas+ cells by tissue-associated CD95 ligand (Fas ligand, FasL) is an important component. One clinical example of the function of an immune privileged site is the success of human corneal transplants, where a very high percentage of transplants accept without tissue matching or immunosuppressive therapy. Since the mouse cornea expresses abundant Fas ligand and immune privilege has been implicated in the success of these transplants, we examined the role of FasL in corneal transplantation. Our results show that human corneas express functional FasL capable of killing Fas+ lymphoid cells in an in vitro culture system. Using a mouse model for corneal allograft transplantation, FasL+ orthografts were accepted at a rate of 45%, whereas FasL- grafts, or normal grafts transplanted to Fas- mice, were rejected 100% of the time. Histological analysis found that FasL+ grafts contained apoptotic mononuclear cells indicating the induction of apoptosis by the graft, while rejecting FasL- corneas contained numerous inflammatory cells without associated apoptosis. Taken together our results demonstrate that FasL expression on the cornea is a major factor in corneal allograft survival and, thus, we provide an explanation for one of the most successful tissue transplants performed in humans.</description><identifier>ISSN: 0021-9738</identifier><identifier>DOI: 10.1172/jci119173</identifier><identifier>PMID: 9022072</identifier><language>eng</language><publisher>United States</publisher><subject>Actins - genetics ; Adolescent ; Adult ; Aged ; Animals ; Apoptosis - immunology ; Child ; Child, Preschool ; Cornea - immunology ; Corneal Transplantation - immunology ; Cytotoxicity, Immunologic ; Fas Ligand Protein ; fas Receptor - immunology ; Female ; Graft Rejection - immunology ; Graft Survival - immunology ; HeLa Cells ; Histocompatibility Testing ; Humans ; Immunohistochemistry ; Immunosuppression ; Infant ; Infant, Newborn ; Inflammation ; Male ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - immunology ; Membrane Glycoproteins - physiology ; Mice ; Middle Aged ; Polymerase Chain Reaction ; RNA, Messenger - analysis ; Transplantation, Homologous - immunology</subject><ispartof>The Journal of clinical investigation, 1997-02, Vol.99 (3), p.396-402</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-ee581354244251c8810b53aed53c3579d5e4e869511d76ea1edc251a834a24763</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC507812/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC507812/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9022072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stuart, P M</creatorcontrib><creatorcontrib>Griffith, T S</creatorcontrib><creatorcontrib>Usui, N</creatorcontrib><creatorcontrib>Pepose, J</creatorcontrib><creatorcontrib>Yu, X</creatorcontrib><creatorcontrib>Ferguson, T A</creatorcontrib><title>CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Although anatomical barriers and soluble mediators have been implicated in immune privilege, it appears that the apoptotic cell death of Fas+ cells by tissue-associated CD95 ligand (Fas ligand, FasL) is an important component. One clinical example of the function of an immune privileged site is the success of human corneal transplants, where a very high percentage of transplants accept without tissue matching or immunosuppressive therapy. Since the mouse cornea expresses abundant Fas ligand and immune privilege has been implicated in the success of these transplants, we examined the role of FasL in corneal transplantation. Our results show that human corneas express functional FasL capable of killing Fas+ lymphoid cells in an in vitro culture system. Using a mouse model for corneal allograft transplantation, FasL+ orthografts were accepted at a rate of 45%, whereas FasL- grafts, or normal grafts transplanted to Fas- mice, were rejected 100% of the time. Histological analysis found that FasL+ grafts contained apoptotic mononuclear cells indicating the induction of apoptosis by the graft, while rejecting FasL- corneas contained numerous inflammatory cells without associated apoptosis. Taken together our results demonstrate that FasL expression on the cornea is a major factor in corneal allograft survival and, thus, we provide an explanation for one of the most successful tissue transplants performed in humans.</description><subject>Actins - genetics</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Apoptosis - immunology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cornea - immunology</subject><subject>Corneal Transplantation - immunology</subject><subject>Cytotoxicity, Immunologic</subject><subject>Fas Ligand Protein</subject><subject>fas Receptor - immunology</subject><subject>Female</subject><subject>Graft Rejection - immunology</subject><subject>Graft Survival - immunology</subject><subject>HeLa Cells</subject><subject>Histocompatibility Testing</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunosuppression</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Inflammation</subject><subject>Male</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Membrane Glycoproteins - physiology</subject><subject>Mice</subject><subject>Middle Aged</subject><subject>Polymerase Chain Reaction</subject><subject>RNA, Messenger - analysis</subject><subject>Transplantation, Homologous - immunology</subject><issn>0021-9738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNpVkE9LAzEQxXNQaq0e_ADCnsQeVvO3yR48yGq1UtCDnkOana0p6aYmuwW_vSstRWFgDu_3Zh4PoQuCbwiR9HZlHSEFkewIDTGmJC8kUyfoNKUVxoRzwQdoUGBKsaRD9FY-FCLzbmmaKruemjQf566pOgtVZjZh04bkUtZPAxZSMvE7q0PMbIgNGJ8Z78MymrrNUhe3bmv8GTqujU9wvt8j9DF9fC-f8_nr06y8n-eWM9HmAEIRJjjlnApilSJ4IZiBSjDLhCwqARzUpBCEVHIChkBle9Aoxg3lcsJG6G53d9Mt1r0ITRuN15vo1n1IHYzT_5XGfepl2GqBpSK091_t_TF8dZBavXbJgvemgdAlLftIhSp4D453oI0hpQj14QfB-rdx_VLOdo337OXfUAdyXzf7AUwbfZQ</recordid><startdate>19970201</startdate><enddate>19970201</enddate><creator>Stuart, P M</creator><creator>Griffith, T S</creator><creator>Usui, N</creator><creator>Pepose, J</creator><creator>Yu, X</creator><creator>Ferguson, T A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19970201</creationdate><title>CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival</title><author>Stuart, P M ; Griffith, T S ; Usui, N ; Pepose, J ; Yu, X ; Ferguson, T A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-ee581354244251c8810b53aed53c3579d5e4e869511d76ea1edc251a834a24763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Actins - genetics</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Apoptosis - immunology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cornea - immunology</topic><topic>Corneal Transplantation - immunology</topic><topic>Cytotoxicity, Immunologic</topic><topic>Fas Ligand Protein</topic><topic>fas Receptor - immunology</topic><topic>Female</topic><topic>Graft Rejection - immunology</topic><topic>Graft Survival - immunology</topic><topic>HeLa Cells</topic><topic>Histocompatibility Testing</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunosuppression</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Inflammation</topic><topic>Male</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Membrane Glycoproteins - physiology</topic><topic>Mice</topic><topic>Middle Aged</topic><topic>Polymerase Chain Reaction</topic><topic>RNA, Messenger - analysis</topic><topic>Transplantation, Homologous - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stuart, P M</creatorcontrib><creatorcontrib>Griffith, T S</creatorcontrib><creatorcontrib>Usui, N</creatorcontrib><creatorcontrib>Pepose, J</creatorcontrib><creatorcontrib>Yu, X</creatorcontrib><creatorcontrib>Ferguson, T A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stuart, P M</au><au>Griffith, T S</au><au>Usui, N</au><au>Pepose, J</au><au>Yu, X</au><au>Ferguson, T A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>1997-02-01</date><risdate>1997</risdate><volume>99</volume><issue>3</issue><spage>396</spage><epage>402</epage><pages>396-402</pages><issn>0021-9738</issn><abstract>Although anatomical barriers and soluble mediators have been implicated in immune privilege, it appears that the apoptotic cell death of Fas+ cells by tissue-associated CD95 ligand (Fas ligand, FasL) is an important component. One clinical example of the function of an immune privileged site is the success of human corneal transplants, where a very high percentage of transplants accept without tissue matching or immunosuppressive therapy. Since the mouse cornea expresses abundant Fas ligand and immune privilege has been implicated in the success of these transplants, we examined the role of FasL in corneal transplantation. Our results show that human corneas express functional FasL capable of killing Fas+ lymphoid cells in an in vitro culture system. Using a mouse model for corneal allograft transplantation, FasL+ orthografts were accepted at a rate of 45%, whereas FasL- grafts, or normal grafts transplanted to Fas- mice, were rejected 100% of the time. Histological analysis found that FasL+ grafts contained apoptotic mononuclear cells indicating the induction of apoptosis by the graft, while rejecting FasL- corneas contained numerous inflammatory cells without associated apoptosis. Taken together our results demonstrate that FasL expression on the cornea is a major factor in corneal allograft survival and, thus, we provide an explanation for one of the most successful tissue transplants performed in humans.</abstract><cop>United States</cop><pmid>9022072</pmid><doi>10.1172/jci119173</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 1997-02, Vol.99 (3), p.396-402
issn 0021-9738
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_507812
source EZB Free E-Journals; PubMed Central
subjects Actins - genetics
Adolescent
Adult
Aged
Animals
Apoptosis - immunology
Child
Child, Preschool
Cornea - immunology
Corneal Transplantation - immunology
Cytotoxicity, Immunologic
Fas Ligand Protein
fas Receptor - immunology
Female
Graft Rejection - immunology
Graft Survival - immunology
HeLa Cells
Histocompatibility Testing
Humans
Immunohistochemistry
Immunosuppression
Infant
Infant, Newborn
Inflammation
Male
Membrane Glycoproteins - genetics
Membrane Glycoproteins - immunology
Membrane Glycoproteins - physiology
Mice
Middle Aged
Polymerase Chain Reaction
RNA, Messenger - analysis
Transplantation, Homologous - immunology
title CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T17%3A20%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CD95%20ligand%20(FasL)-induced%20apoptosis%20is%20necessary%20for%20corneal%20allograft%20survival&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Stuart,%20P%20M&rft.date=1997-02-01&rft.volume=99&rft.issue=3&rft.spage=396&rft.epage=402&rft.pages=396-402&rft.issn=0021-9738&rft_id=info:doi/10.1172/jci119173&rft_dat=%3Cproquest_pubme%3E78819894%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-ee581354244251c8810b53aed53c3579d5e4e869511d76ea1edc251a834a24763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78819894&rft_id=info:pmid/9022072&rfr_iscdi=true